H.C. Wainwright has maintained a positive stance on Xenon, reiterating a Buy rating and a price target of $53.00 due to the potential of azetukalner, Xenon's new antiseizure medication.

Analyst firms have expressed optimism about Xenon's trajectory. H.C. Wainwright has maintained a Buy rating and a price target of $53.00 for Xenon, due to the potential of Azetukalner. RBC Capital ...

The thrust generated by xenon is only 0.1 newtons, roughly the weight of a piece of paper, but can gradually (over many months) increase the velocity of the spacecraft by 15,000 km h −1.